Technical Analysis for TSRO - TESARO, Inc.

Grade Last Price % Change Price Change
grade F 60.74 -0.25% -0.15
TSRO closed down 0.25 percent on Friday, February 23, 2018, on 59 percent of normal volume.

Earnings due: Feb 27

1 Watcher
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical TSRO trend table...

Date Alert Name Type % Chg
Feb 23 Multiple of Ten Bullish Other 0.00%
Feb 23 Wide Bands Range Expansion 0.00%
Feb 23 Down 3 Days in a Row Weakness 0.00%
Feb 22 Wide Bands Range Expansion -0.25%
Feb 21 Shooting Star Candlestick Bearish -2.05%
Feb 21 Doji - Bearish? Reversal -2.05%
Feb 21 Wide Bands Range Expansion -2.05%
Feb 20 Multiple of Ten Bullish Other -2.50%
Feb 20 Wide Bands Range Expansion -2.50%
Feb 16 1,2,3 Retracement Bearish Bearish Swing Setup 0.15%

Older signals for TSRO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
TESARO, Inc., an oncology-focused biopharmaceutical company, engages in the identification, acquisition, development, and commercialization of oncology therapeutics and supportive care products in the United States, Europe, and other international markets. Its product portfolio consist of the Rolapitant, a neurokinin-1 receptor antagonist, which is in Phase III clinical trials for the prevention of chemotherapy induced nausea and vomiting; Niraparib, an orally active and potent poly polymerase inhibitor that has undergone a Phase I clinical trial in cancer patients; and TSR-011, an orally available anaplastic lymphoma kinase inhibitor, which is in Phase 1/2 dose escalation clinical trials in cancer patients. The company was founded in 2010 and is headquartered in Waltham, Massachusetts.
Is TSRO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 189.97
52 Week Low 55.02
Average Volume 1,050,159
200-Day Moving Average 109.2326
50-Day Moving Average 70.0754
20-Day Moving Average 61.868
10-Day Moving Average 60.873
Average True Range 3.4887
ADX 30.19
+DI 17.54
-DI 24.16
Chandelier Exit (Long, 3 ATRs ) 63.1039
Chandelier Exit (Short, 3 ATRs ) 65.4861
Upper Bollinger Band 68.7384
Lower Bollinger Band 54.9976
Percent B (%b) 0.42
BandWidth 22.209866
MACD Line -2.6733
MACD Signal Line -3.3944
MACD Histogram 0.7211
Fundamentals Value
Market Cap 3.29 Billion
Num Shares 54.1 Million
EPS -9.95
Price-to-Earnings (P/E) Ratio -6.10
Price-to-Sales 148.54
Price-to-Book 15.32
PEG Ratio -0.53
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 64.10
Resistance 3 (R3) 64.14 63.07 63.54
Resistance 2 (R2) 63.07 62.21 63.05 63.35
Resistance 1 (R1) 61.90 61.68 61.37 61.86 63.17
Pivot Point 60.83 60.83 60.56 60.81 60.83
Support 1 (S1) 59.66 59.97 59.13 59.62 58.31
Support 2 (S2) 58.59 59.44 58.57 58.13
Support 3 (S3) 57.42 58.59 57.94
Support 4 (S4) 57.38